Physician profile
Gerard M Librodo
NPI 1629003223
$26,599.63
in general payments reported to CMS, 2019-2025
36 companies · $914 in 2025
The $914 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $1,444 · 2021: $3,881 · 2022: $2,251 · 2023: $4,646 · 2024: $3,282 · 2025: $914.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,357 · Travel and Lodging: $1,485 · Gift: $999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,356.50 |
| Travel and Lodging | $1,485.31 |
| Gift | $999.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $7,771.39 | 2019-2021 | |
| Ctl Medical Corporation | $3,268.45 | 2021-2025 | Spinal, Raphael Pedicle Screw System |
| Integrity Implants INC. Dba Accelus | $2,333.19 | 2023 | |
| Biocomposites INC | $2,040.67 | 2019-2024 | Stimulan |
| Precision Spine, INC. | $1,623.32 | 2020-2025 | |
| Kyocera Medical Technologies, INC. | $1,556.48 | 2021-2023 | |
| Amplify Surgical, INC. | $1,180.03 | 2021-2023 | Dualx and Dualportal |
| Surgalign Spine Technologies, INC. | $1,005.32 | 2019-2021 | |
| Kuros Biosciences USA, INC | $973.71 | 2022-2023 | |
| Relievant Medsystems, INC. | $729.05 | 2019 | |
| Eminent Spine, LLC | $678.05 | 2024 | |
| Sivantage, INC. | $605.28 | 2024 | |
| Integrity Implants INC. | $506.72 | 2019-2021 | Flarehawk |
| Innovasis INC | $258.14 | 2020-2023 | |
| Nexxt Spine LLC | $258.06 | 2020-2025 | Nexxt Matrixx Product Review, Inertia Revision |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zavation Medical Products, LLC | $206.76 | 2021 | |
| Aesculap, INC. | $185.83 | 2022-2024 | Elan 4 |
| Richard Wolf Medical Instruments Corp. | $167.42 | 2019 | |
| Baudax Bio INC. | $166.68 | 2020-2021 | |
| Curiteva, INC. | $149.55 | 2025 | |
| Ossdsign USA Incorporated | $144.13 | 2025 | Ossdsign Catalyst |
| Camber Spine Technologies LLC | $141.31 | 2021 | |
| Augmedics INC. | $124.10 | 2024 | Xvision |
| Innovation Technologies INC | $90.14 | 2021 | |
| Spineology INC. | $83.59 | 2021 | |
| Nevro Corp. | $70.94 | 2021 | |
| Republic Spine | $59.57 | 2022 | |
| Medacta USA, INC. | $53.23 | 2020 | |
| Cerapedics INC. | $33.27 | 2019 | |
| Spine Wave, INC. | $27.39 | 2024 | Proficient Posterior Cervical Spine System |
| Electronic Waveform Lab, INC. | $26.83 | 2023 | |
| Ulrich Medical USA, INC. | $26.55 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $16.56 | 2023 | Iovera, Zilretta, Exparel |
| Orthofix Medical, INC. | $13.83 | 2019 | |
| Medtronic USA, INC. | $12.30 | 2020 | |
| Collegium Pharmaceutical, INC. | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerard Librodo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.